Said Darwazah, Hikma’s executive chairman and former CEO, will assume all CEO responsibilities; Hikma’s board has initiated the process to identify a new CEO.
A distinct set of PBM business practices have resulted in higher prices and delayed access to generics and biosimilars for patients, according to AAM CEO Dan Leonard.
The organization shared information with healthcare providers and parents in light of the infant formula shortage, and the maker of Enfamil is reportedly going forward with a sale of its business.
The analysis found that only 22% (513) of the test to treat sites are in the most vulnerable areas in the country as defined by the Social Vulnerability Index.
